Causal claim
Sgk1 Inhibitor Treatment Depressive EpisodeThey pull in opposite directions: more cause, less effect. The map scores it at 25% confidence, weighed from 1 article.
Drugs that block SGK1 could offer a new antidepressant mechanism, especially for SSRI-resistant patients
Nothing upstream on the map yet.